Current report
Open the filing on sec.gov
FitLife Brands, Inc. (FTLF)
Nasdaq: FTLF · Medicinal Chemicals & Botanical Products · Omaha, NE · filing with the SEC since 2006
Grade5.8
◀ Past 5.3● Present 5.8▶ Future 6.5
The companyfiscal 2025, as filed
Revenue$81.5M+26.4%
Net income$6.3M-29.6%
Earnings per share$0.63-30.8%
Operating cash flow$7.4M-22.6%
Cashn/a
Debtn/a
Shareholders’ equity$43.6M+20.8%
Shares, diluted9,977,000+0.8%
Return on equity14.5%
The recordfrom its filings
Filings in 202621
Newest filingSep 9 · 8-K
Annual reportMar 31, 2026
Quarterly reportAug 13, 2026
Next report due10-Q by Nov 14
Insider sales, 12 months$0.00
Insider buys, 12 months$100,000
Patents granted8
Filer categoryNon-accelerated filer<br>Smaller reporting company
Trailing twelve months to Jun 2026Revenue $75.4MNet income $6.2MCash from operations $10.0Mthe four newest filed quarters added
Left: the newest annual report, with the change on the year before. Right: counted from the company's own filings with the SEC.
As filed, in USD. Nothing here is a forecast.
News
Insider trade report
Open the filing on sec.gov
Insider trade report
Open the filing on sec.gov
Results released
Open the filing on sec.gov
Quarterly report
Open the filing on sec.gov
Large holder update, amended
Open the filing on sec.gov
Extra proxy material
Open the filing on sec.gov
Extra proxy material
Open the filing on sec.gov
Proxy statement
Open the filing on sec.gov
Current report
Open the filing on sec.gov
Nothing of this kind is on the record for this company yet.
An outside story is shown by its headline, its source and its link only. The SI reads the page when you ask it to break one down.